Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |